Literature DB >> 19728497

Are you taking the lead?

Jon S Friedland.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19728497      PMCID： PMC4952491          DOI： 10.7861/clinmedicine.9-4-305

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN： 1470-2118            Impact factor:   2.659


× No keyword cloud information.
  4 in total

1.  Wide geographic spread of diverse acquired AmpC beta-lactamases among Escherichia coli and Klebsiella spp. in the UK and Ireland.

Authors:  Neil Woodford; Suganya Reddy; Elizabeth J Fagan; Robert L R Hill; Katie L Hopkins; Mary E Kaufmann; James Kistler; Marie-France I Palepou; Rachel Pike; M Elaina Ward; John Cheesbrough; David M Livermore
Journal:  J Antimicrob Chemother       Date:  2006-11-16       Impact factor: 5.790

Review 2.  Guidelines for UK practice for the diagnosis and management of methicillin-resistant Staphylococcus aureus (MRSA) infections presenting in the community.

Authors:  Dilip Nathwani; Marina Morgan; Robert G Masterton; Matthew Dryden; Barry D Cookson; Gary French; Deirdre Lewis
Journal:  J Antimicrob Chemother       Date:  2008-03-13       Impact factor: 5.790

Review 3.  Clostridium difficile--more difficult than ever.

Authors:  Ciarán P Kelly; J Thomas LaMont
Journal:  N Engl J Med       Date:  2008-10-30       Impact factor: 91.245

4.  Mortality following bacteraemic infection caused by extended spectrum beta-lactamase (ESBL) producing E. coli compared to non-ESBL producing E. coli.

Authors:  Mark Melzer; Irene Petersen
Journal:  J Infect       Date:  2007-06-14       Impact factor: 6.072
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.